Related Experiment Videos
Nutritional Factors and Weight Loss Predict Tracheostomy-Free Survival in Multiple System Atrophy
Yuri Asano1, Kota Bokuda1, Kentaro Hayashi2
1Department of Neurology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.
Movement Disorders Clinical Practice
|August 7, 2026
Summary
Nutritional decline, indicated by lower prognostic nutritional index (PNI) and greater body mass index (BMI) decline (∆BMI), predicts shorter survival in Multiple System Atrophy (MSA) patients. Monitoring nutrition is crucial for improving outcomes.
Area of Science:
- Neurology
- Nutritional Science
Background:
- Multiple System Atrophy (MSA) is characterized by progressive weight loss and nutritional decline.
- The prognostic impact of specific nutritional factors in MSA is not well understood.
Purpose of the Study:
- To evaluate the prognostic value of nutritional parameters, specifically prognostic nutritional index (PNI) and annual body mass index (BMI) decline (∆BMI), in MSA patients.
- To identify key predictors of survival in individuals diagnosed with MSA.
Main Methods:
- Retrospective analysis of 215 MSA patients diagnosed using 2022 Movement Disorder Society Criteria.
- Assessment of baseline parameters including PNI, BMI, and Unified MSA Rating Scale (UMSARS) scores.
- Calculation of annual BMI decline (∆BMI) post-diagnosis and survival analysis using log-rank and Cox proportional hazards models.
Main Results:
- Lower PNI, greater ∆BMI, higher UMSARS Part I-item 2 scores, and orthostatic hypotension were associated with shorter survival.
- Multivariate analysis confirmed PNI (HR 2.12), ∆BMI (HR 2.90), and UMSARS Part I-item 2 scores (HR 1.59) as independent predictors of reduced survival.
Conclusions:
- Nutritional decline, reflected by PNI and ∆BMI, independently predicts shorter survival in MSA.
- These findings highlight the importance of monitoring nutritional status alongside swallowing function for better clinical management of MSA patients.
Related Concept Videos
Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Oxygen Delivering System III: Tracheostomy and T-piece
Oxygen delivery is critical in clinical care, especially for patients with respiratory disorders or those undergoing surgical procedures. Various systems, such as tracheostomy and the T-piece, deliver oxygen to the lungs, ensuring adequate arterial oxygenation.
Tracheostomy
A tracheostomy is a surgically created opening (stoma) in the anterior part of the trachea. It is used to establish a patient airway, bypass an upper airway obstruction, simplify the removal of secretions, permit long-term...
Tracheostomy
A tracheostomy is a surgically created opening (stoma) in the anterior part of the trachea. It is used to establish a patient airway, bypass an upper airway obstruction, simplify the removal of secretions, permit long-term...
Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Trachea
The trachea, commonly known as the windpipe, is a vital part of the human respiratory system. It serves as a passageway for air to travel between the larynx and the bronchi, allowing oxygen to reach the lungs. Let's explore its anatomical features, dimensions, layers of the tracheal wall, associated muscles, and the functions of its parts.
Anatomical Features:
Location: About half of the trachea is situated in the neck, anterior to the esophagus, and extends from the larynx (at the level of the...
Anatomical Features:
Location: About half of the trachea is situated in the neck, anterior to the esophagus, and extends from the larynx (at the level of the...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.